Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-037168
Filing Date
2013-07-18
Accepted
2013-07-18 14:25:35
Documents
2
Period of Report
2013-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4032
2 POA DOCUMENT poa.txt EX-24.4_481754 3066
  Complete submission text file 0001209191-13-037168.txt   8519
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MIRATI THERAPEUTICS INC. 4660 LA JOLLA VILLAGE DRIVE, SUITE 500 SAN DIEGO CA 92121
Business Address
BAUM CHARLES M (Reporting) CIK: 0001579824 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 13974644